These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36969895)

  • 1. Breath Biopsy
    Ferrandino G; De Palo G; Murgia A; Birch O; Tawfike A; Smith R; Debiram-Beecham I; Gandelman O; Kibble G; Lydon AM; Groves A; Smolinska A; Allsworth M; Boyle B; van der Schee MP; Allison M; Fitzgerald RC; Hoare M; Snowdon VK
    J Clin Transl Hepatol; 2023 Jun; 11(3):638-648. PubMed ID: 36969895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
    Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
    JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel breath biomarkers identification for early detection of hepatocellular carcinoma and cirrhosis using ML tools and GCMS.
    Ain Nazir NU; Shaukat MH; Luo R; Abbas SR
    PLoS One; 2023; 18(11):e0287465. PubMed ID: 37967076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
    Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of volatile organic compounds to diagnose primary sclerosing cholangitis.
    van Vorstenbosch R; van Munster K; Stavropoulos G; Pachen D; van Schooten FJ; Ponsioen C; Smolinska A
    JHEP Rep; 2024 Aug; 6(8):101103. PubMed ID: 39131082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.
    Ferrandino G; Orf I; Smith R; Calcagno M; Thind AK; Debiram-Beecham I; Williams M; Gandelman O; de Saedeleer A; Kibble G; Lydon AM; Mayhew CA; Allsworth M; Boyle B; van der Schee MP; Allison M; Hoare M; Snowdon VK
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00239. PubMed ID: 33094960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous Volatile Organic Compound (EVOC
    Ferrandino G; Ricciardi F; Murgia A; Banda I; Manhota M; Ahmed Y; Sweeney K; Nicholson-Scott L; McConville L; Gandelman O; Allsworth M; Boyle B; Smolinska A; Ginesta Frings CA; Contreras J; Asenjo-Lobos C; Barrientos V; Clavo N; Novoa A; Riviotta A; Jerez M; Méndez L
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001958
    [No Abstract]   [Full Text] [Related]  

  • 10. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
    Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
    J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples.
    Fernández Del Río R; O'Hara ME; Holt A; Pemberton P; Shah T; Whitehouse T; Mayhew CA
    EBioMedicine; 2015 Sep; 2(9):1243-50. PubMed ID: 26501124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Non-invasive Diagnostic Method for Esophageal Squamous Cell Carcinoma by Gas Chromatographic Analysis of Exhaled Breath.
    Matsumori S; Hashimoto T; Nasu M; Kaga N; Taka H; Fujimura T; Ueno T; Miura Y; Kajiyama Y
    Juntendo Iji Zasshi; 2022; 68(5):499-504. PubMed ID: 39081580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.
    Di Gilio A; Catino A; Lombardi A; Palmisani J; Facchini L; Mongelli T; Varesano N; Bellotti R; Galetta D; de Gennaro G; Tangaro S
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Chandran D; Ooi EH; Watson DI; Kholmurodova F; Jaenisch S; Yazbeck R
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242578
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of breast cancer risk with volatile biomarkers in breath.
    Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S
    Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Stress Biomarkers in Exhaled Breath of Workers Exposed to Crystalline Silica Dust by SPME-GC-MS.
    Jalali M; Zare Sakhvidi MJ; Bahrami A; Berijani N; Mahjub H
    J Res Health Sci; 2016; 16(3):153-161. PubMed ID: 27840344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.